<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR70">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rodrigues</surname>
    <given-names>GA</given-names>
   </name>
   <name>
    <surname>Shalaev</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Karami</surname>
    <given-names>TK</given-names>
   </name>
   <name>
    <surname>Cunningham</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Slater</surname>
    <given-names>NKH</given-names>
   </name>
   <name>
    <surname>Rivers</surname>
    <given-names>HM</given-names>
   </name>
  </person-group>
  <article-title>Pharmaceutical development of AAV-based gene therapy products for the eye</article-title>
  <source>Pharm Res</source>
  <year>2018</year>
  <volume>36</volume>
  <issue>2</issue>
  <fpage>29</fpage>
  <pub-id pub-id-type="doi">10.1007/s11095-018-2554-7</pub-id>
  <?supplied-pmid 30591984?>
  <pub-id pub-id-type="pmid">30591984</pub-id>
 </element-citation>
</ref>
